Form 4 for JRI Nuveen Real Asset Income & Growth Fund
Accepted 2026-03-18 00:00:00 ET · period of report 2026-03-16 · accession 0001225208-26-003807 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-03-18 | 2026-03-16 | JRI | Jones Nathaniel T. | VP | X - OptEx | $12.40 | +750 | 1,750 | +75% | +$9,300 |
| D | 2026-03-18 | 2026-03-16 | JRI | Jones Nathaniel T. | VP | X - OptEx | $12.40 | -1,000 | 0 | -100% | -$12.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-16 | X | A | 750 | $12.40 | 1,750 | D | — | — | (F1) Represents shares acquired upon exercise of subscription rights, including rights to related oversubscription privileges, allocated to the Reporting Person in the pro rata rights offering conducted by the Issuer. Theacquisition of the rights by the Reporting Person was exempt from Section 16 by virtue of Rule 16a-9(b) and the acquisition of shares by the Reporting Person upon exercise of the rights was exempt from Section 16(b) byvirtue of Section 16b-6(b). |
| 2 | Derivative | Subscription Right | 2026-03-16 | X | D | 1,000 | $12.40 | 0 | D | $12.40 · 2026-02-06 to 2026-03-09 | 1,000 Common Stock |